The market has been down on ENDRA Life Sciences Inc (NDRA) stock recently. NDRA gets a Bearish score from InvestorsObserver Stock Sentiment Indicator.
ENDRA Life Sciences Inc has a Bearish sentiment reading. Find out what this means for you and get the rest of the rankings on NDRA!
What is Stock Sentiment?
When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With NDRA Stock Today?
ENDRA Life Sciences Inc (NDRA) stock is trading at $1.49 as of 11:02 AM on Friday, Jun 2, a rise of $0.08, or 6.06% from the previous closing price of $1.40. The stock has traded between $1.45 and $1.53 so far today. Volume today is low. So far 18,393 shares have traded compared to average volume of 69,157 shares.
To see InvestorsObserver's Sentiment Score for ENDRA Life Sciences Inc click here.
More About ENDRA Life Sciences Inc
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
Click Here to get the full Stock Report for ENDRA Life Sciences Inc stock.